The Value of Immunization Compendium of Evidence (VoICE) is a searchable database of peer-reviewed, scientific evidence demonstrating the broad benefits of imm

The VIEW-hub report displays data and figures on the introduction, use, and coverage status of pneumococcal, rotavirus, and inactivated polio vaccines both globally and in the 73 Gavi countries as of March 2018.

The VIEW-hub report displays data and figures on the introduction, use, and coverage status of pneumococcal, rotavirus, and inactivated polio vaccines both globally and in the 73 Gavi countries as of December 2017.

The VIEW-hub report displays data and figures on the introduction, use, and coverage status of pneumococcal, rotavirus, and inactivated polio vaccines both globally and in the 73 Gavi countries as of September 2017.

The VIEW-hub report displays data and figures on the introduction, use, and coverage status of pneumococcal, rotavirus, and inactivated polio vaccines both globally and in the 73 Gavi countries as of June 2017.

The VIEW-hub report displays data and figures on the introduction, use, and coverage status of pneumococcal, rotavirus, and inactivated polio vaccines both globally and in the 73 Gavi countries as of March 2017.

This report summarizes the use of pneumococcal conjugate vaccine (PCV) and impact evidence as of November 2016 in countries routinely using PCV10 or PCV13.

The VIEW-hub report displays data and figures on the introduction, use, and coverage status of pneumococcal, rotavirus, and inactivated polio vaccines both globally and in the 73 Gavi countries asof December 2016.

The VIEW-hub report displays data and figures on the introduction, use, and coverage status of pneumococcal, rotavirus, and inactivated polio vaccines both globally and in the 73 Gavi countries as of September 2016.

The VIEW-hub report displays data and figures on the introduction, use, and coverage status of pneumococcal, rotavirus, and inactivated polio vaccines both globally and in the 73 Gavi countries as of June 2016..